https://www.selleckchem.com/pr....oducts/adavivint.htm
Reduced renal function was associated with higher rates of the primary endpoint (severe CKD vs. moderate CKD vs. no CKD 30.2% vs. 12.5% vs. 9.1%, P less then 0.01) as well as major bleeding (10.3% vs. 8.9% vs. 6.4%, P = 0.03). After adjustment, severe CKD and moderate CKD in HBR patients remained independent predictors for the primary endpoint (HR [95%CI] 2.84 [1.94-4.16], P less then 0.01, 1.48 [1.10-2.00], P less then 0.01) compared to those with no CKD. However, decreased renal function was no longer significantly associated
Like
Comment
Share
